Search

Your search keyword '"Rybicki, Lisa A."' showing total 397 results
Start Over Author "Rybicki, Lisa A." Search Limiters Academic (Peer-Reviewed) Journals
397 results on '"Rybicki, Lisa A."'

5. Allogeneic blood or marrow transplantation with haploidentical donor and post-transplantation cyclophosphamide in patients with myelofibrosis: a multicenter study

Author

Kunte, Siddharth, Rybicki, Lisa, Viswabandya, Auro, Tamari, Roni, Bashey, Asad, Keyzner, Alla, Iqbal, Madiha, Grunwald, Michael R., Dholaria, Bhagirathbhai, Elmariah, Hany, Ozga, Michael, Singh, Anurag, Abedin, Sameem, DeZern, Amy E., Jones, Richard J., Gupta, Vikas, Gerds, Aaron T., and Jain, Tania

Published
2022
Full Text
View/download PDF

8. Identifying an oligometastatic phenotype in HPV-associated oropharyngeal squamous cell cancer: Implications for clinical trial design

Author

Fleming, Christopher W., Ward, Matthew C., Woody, Neil M., Joshi, Nikhil P., Greskovich, John F., Jr, Rybicki, Lisa, Xiong, David, Contrera, Kevin, Chute, Deborah J., Milas, Zvonimir L., Frenkel, Catherine H., Brickman, Daniel S., Carrizosa, Daniel R., Ku, Jamie, Prendes, Brandon, Lamarre, Eric, Lorenz, Robert R., Scharpf, Joseph, Burkey, Brian B., Schwartzman, Larisa, Geiger, Jessica L., Adelstein, David J., and Koyfman, Shlomo A.

Published
2021
Full Text
View/download PDF

11. Influence of major histocompatibility complex class I chain-related gene A polymorphisms on cytomegalovirus disease after allogeneic hematopoietic cell transplantation

Author

Patel, Sagar S., Rybicki, Lisa A., Yurch, Melissa, Thomas, Dawn, Liu, Hien, Dean, Robert, Jagadeesh, Deepa, Hill, Brian, Pohlman, Brad, Bolwell, Brian, Hanna, Rabi, Hamilton, Betty K., Kalaycio, Matt, Gerds, Aaron T., Cober, Eric, Mossad, Sherif, Zhang, Aiwen, Majhail, Navneet S., Askar, Medhat, and Sobecks, Ronald

Published
2020
Full Text
View/download PDF

14. Patient-Reported Outcomes in Long-Term Survivors of Autologous Hematopoietic Cell Transplantation in Multiple Myeloma

Author

Chakraborty, Rajshekhar, Yi, Jean, Rybicki, Lisa, Preussler, Jaime, Deol, Abhinav, Loren, Alison, Savani, Bipin, Jim, Heather S.L., Cerny, Jan, Reynolds, Jana, Whitten, Jennifer, Wingard, John R., McGuirk, Joseph P., Uberti, Joseph, Khera, Nandita, Stiff, Patrick, Jaglowski, Samantha M., Hashmi, Shahrukh, Holtan, Shernan G., Devine, Steven, Hahn, Theresa, Whalen, Victoria L., Saber, Wael, Wood, William, Baker, K. Scott, Syrjala, Karen, and Majhail, Navneet S.

Published
2023
Full Text
View/download PDF

20. Efficacy of Standard Dose R-CHOP Alternating With R-HDAC Followed by Autologous Hematopoietic Cell Transplantation as Initial Therapy of Mantle Cell Lymphoma, a Single-Institution Experience

Author

Sawalha, Yazeed, Hill, Brian T., Rybicki, Lisa A., Sun, Danyu, Dean, Robert M., Jagadeesh, Deepa, Hamilton, Betty K., Gerds, Aaron T., Sobecks, Ronald M., Andresen, Steven, Liu, Hien K., Majhail, Navneet S., Pohlman, Brad, Kalaycio, Matt E., Bolwell, Brian J., and Smith, Mitchell R.

Published
2018
Full Text
View/download PDF

26. Music Therapy for Symptom Management After Autologous Stem Cell Transplantation: Results From a Randomized Study

Author

Bates, Debbie, Bolwell, Brian, Majhail, Navneet S., Rybicki, Lisa, Yurch, Melissa, Abounader, Donna, Kohuth, Joseph, Jarancik, Shannon, Koniarczyk, Heather, McLellan, Linda, Dabney, Jane, Lawrence, Christine, Gallagher, Lisa, Kalaycio, Matt, Sobecks, Ronald, Dean, Robert, Hill, Brian, Pohlman, Brad, Hamilton, Betty K., Gerds, Aaron T., Jagadeesh, Deepa, and Liu, Hien D.

Published
2017
Full Text
View/download PDF

27. Allogeneic Hematopoietic Cell Transplantation for Adult T Cell Acute Lymphoblastic Leukemia

Author

Hamilton, Betty Ky, Rybicki, Lisa, Abounader, Donna, Adekola, Kehinde, Advani, Anjali, Aldoss, Ibrahim, Bachanova, Veronika, Bashey, Asad, Brown, Stacey, DeLima, Marcos, Devine, Steven, Flowers, Christopher R., Ganguly, Siddharth, Jagasia, Madan, Kennedy, Vanessa E., Kim, Dennis Dong Hwan, McGuirk, Joseph, Pullarkat, Vinod, Romee, Rizwan, Sandhu, Karamjeet, Smith, Melody, Ueda, Masumi, Viswabandya, Auro, Vu, Khoan, Wall, Sarah, Zeichner, Simon B., Perales, Miguel-Angel, and Majhail, Navneet S.

Published
2017
Full Text
View/download PDF

28. Influence of Killer Immunoglobulin-Like Receptors and Somatic Mutations on Transplant Outcomes in Acute Myeloid Leukemia

Author

Hong, Sanghee, Rybicki, Lisa, Zhang, Aiwen, Thomas, Dawn, Kerr, Cassandra M., Durrani, Jibran, Rainey, Magdalena A., Mian, Agrima, Behera, Tapas R., Carraway, Hetty E., Nazha, Aziz, Mukherjee, Sudipto, Advani, Anjali S., Patel, Bhumika, Kalaycio, Matt, Bolwell, Brian J., Hanna, Rabi, Gerds, Aaron T., Pohlman, Brad, Hamilton, Betty K., Sekeres, Mikkael A., Majhail, Navneet S., Maciejewski, Jaroslaw P., Askar, Medhat, and Sobecks, Ronald

Published
2021
Full Text
View/download PDF

29. Comparative Effectiveness of Busulfan and Fludarabine versus Fludarabine and 400 cGy Total Body Irradiation Conditioning Regimens for Acute Myeloid Leukemia/Myelodysplastic Syndrome

Author

Mustafa Ali, Moaath, Abounader, Donna M., Rybicki, Lisa A., Yurch, Melissa A., Starn, Jamie, Ferraro, Christina, Winslow, Victoria, Hamilton, Betty K., Gerds, Aaron T., Liu, Hien, Dean, Robert, Hill, Brian T., Pohlman, Brad, Andresen, Steven, Hanna, Rabi, Kalaycio, Matt, Bolwell, Brian J., Majhail, Navneet S., and Sobecks, Ronald M.

Published
2017
Full Text
View/download PDF

30. Response Rates to Methylnaltrexone in Hospitalized Cancer Patients.

Author

Harris, David, Kalir, David, Chevalier, Cory, Dobbie, Krista, Fielding, Flannery, Lagman, Ruth, Makhoul, Ahed, McInnes, Susan, Najafi, Sina, Neale, Kyle, Rybicki, Lisa, Robbins-Ong, Melanie, and Neuendorf, Kathleen

Abstract

Context: Methylnaltrexone is a peripherally-acting mu-opioid receptor antagonist studied in both cancer and non-cancer patients with opioid-induced constipation (OIC), but mostly in the outpatient setting. For adult hospitalized cancer patients with OIC, its effectiveness is unknown. Objectives: Describe the efficacy of methylnaltrexone for OIC in the inpatient setting, defined as bowel movement (BM) within 24 hours of methylnaltrexone administration. Methods: We performed a single-center, retrospective chart review of all hospitalized, adult patients with a cancer diagnosis who received methylnaltrexone from the palliative care team between January 1st, 2012 and July 1st, 2019. Results: We identified 194 patients. The mean age was 59, 50.5% were male and 88% were white. 192 patients (98%) received the 8 mg dose subcutaneously. The median oral morphine equivalent (OME) was 135 mg (IQR 70-354 mg). 45% (95% confidence interval, 38-53%) had a BM within 24 hours. Higher OME was correlated with successful BM, with a response in 93% (86/92) of patients receiving ≥150 OME and 2% (2/102) of patients receiving <150 OME (P <.0001). Prior laxative use did not predict response at 24 hours whether these were osmotic laxatives (40.7% vs 47.1%, P =.52), stimulant laxatives (45.7% vs 45.2%, P >.99), or stool softeners (44.7% vs 46.1%, P =.89). Conclusion: Methylnaltrexone has a high response rate when used as treatment for OIC in hospitalized adult cancer patients, especially for patients taking ≥150 OME. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

41. Synergistic Effect of Major Histocompatibility Complex Class I–Related Chain A and Human Leukocyte Antigen–DPB1 Mismatches in Association with Acute Graft-versus-Host Disease after Unrelated Donor Hematopoietic Stem Cell Transplantation

Author

Askar, Medhat, Sun, Yuchu, Rybicki, Lisa, Zhang, Aiwen, Thomas, Dawn, Kalaycio, Matt, Pohlman, Brad, Dean, Robert, Duong, Hien, Hanna, Rabi, Maciejewski, Jaroslaw, Majhail, Navneet S., Bolwell, Brian, and Sobecks, Ronald

Published
2014
Full Text
View/download PDF

42. A Phase II Trial of Induction Epirubicin, Oxaliplatin, and Fluorouracil, Followed by Surgery and Postoperative Concurrent Cisplatin and Fluorouracil Chemoradiotherapy in Patients with Locoregionally Advanced Adenocarcinoma of the Esophagus and Gastroesophageal Junction

Author

McNamara, Michael J., Adelstein, David J., Bodmann, Joanna W., Greskovich, John F., Jr., Ives, Denise I., Mason, David P., Murthy, Sudish C., Rice, Thomas W., Saxton, Jerrold P., Sohal, Davendra, Stephans, Kevin, Rodriguez, Cristina P., Videtic, Gregory M.M., and Rybicki, Lisa A.

Published
2014
Full Text
View/download PDF

46. Characteristics of Patients with Cancer Readmitted Within 30 Days to an Acute Palliative Care Unit.

Author

El Hachem, Pierre, Pasniciuc, Silviu, Khurana, Saurabh, Samala, Renato V., Rybicki, Lisa A., Lagman, Ruth L., and Davis, Mellar P.

Subjects
CANCER patients, PATIENT readmissions, PALLIATIVE treatment, THROMBOEMBOLISM, HOSPITAL care
Abstract

Objective(s): For patients with cancer, the emergence of acute palliative care units (APCU) may hold promise in curtailing hospital readmissions. The study aims to describe the characteristics of patients readmitted to an APCU. Methods: This retrospective study examined patients with cancer readmitted within 30 days to an APCU. Readmissions were further classified as either potentially preventable or non-preventable. Results: Out of 734 discharges from July 1, 2014 to July 1, 2015, 69 (9%) readmissions were identified and analyzed. For index admissions, median length of stay was five days, and one (1%) was discharged home with hospice care. For readmissions, median time from index admission to readmission was nine days, median length of stay was six days, three (4%) patients died, and 20 (30%) went home with hospice. Ten (14.5%) readmissions were deemed potentially preventable (95% CI 7.2-25.0%). Race/ethnicity—White/Black/Hispanic/Others—was 60%, 10%, 20% and 10%, respectively, among potentially preventable readmissions and 76%, 22%, 2% and 0%, respectively, among potentially non-preventable readmissions (P =.012). Potentially preventable readmissions were more likely to have venous thromboembolism (40% vs. 12%, P =.046) and more reasons for readmission (median 2 vs. 1, P =.019). Conclusions: Among patients with cancer readmitted to an APCU, one out of seven was potentially preventable and a far larger proportion was discharged with hospice care compared to the index admission. Recognition of disease course, meaningful goals of care discussions and timely transition to hospice care may reduce rehospitalization in this population. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

47. Defining Incidence, Risk Factors, and Impact on Survival of Central Line-Associated Blood Stream Infections Following Hematopoietic Cell Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome

Author

Lukenbill, Joshua, Rybicki, Lisa, Sekeres, Mikkael A., Zaman, Muhammad Omer, Copelan, Alexander, Haddad, Housam, Fraser, Thomas, DiGiorgio, Megan J., Hanna, Rabi, Duong, Hien, Hill, Brian, Kalaycio, Matt, Sobecks, Ronald, Bolwell, Brian, and Copelan, Edward

Published
2013
Full Text
View/download PDF

50. Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma: an adenocarcinoma with frequent signet ring cell differentiation, rectal and sigmoid involvement, and adverse morphologic features

Author

Chang, Daniel T, Pai, Rish K, Rybicki, Lisa A, Dimaio, Michael A, Limaye, Maneesha, Jayachandran, Priya, Koong, Albert C, Kunz, Pamela A, Fisher, George A, Ford, James M, Welton, Mark, Shelton, Andrew, Ma, Lisa, Arber, Daniel A, and Pai, Reetesh K

Published
2012
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results